Evidence map›Paper›PMID 29174079›Full record

Trial reportThe Journal of pediatrics2018

Laryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial.

Kari D Roberts, Roland Brown, Andrea L Lampland, Tina A Leone, Kyle D Rudser, Neil N Finer, Wade D Rich, T Allen Merritt, Adam J Czynski, Julie M Kessel and 3 more

2 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The Journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 10 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01116921 nacompletednot on this map

Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates

TypeinterventionalSponsorUniversity of MinnesotaRan2011 to 2015Enrolled103ConditionsRespiratory Distress SyndromeArmsNasal continuous positive airway pressure (nCPAP), Laryngeal Mask Airway (LMA) to deliver surfactant, Surfactants, Pulmonary
NCT07030270 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Clinical Trial Comparing Surfactant Administration Through Supraglottic Airway or Thin Catheter for Preterm Infants

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2026 to 2030Enrolled40ConditionsSurfactant, Respiratory Distress Syndrome (Neonatal)ArmsSurfactant Administration through Laryngeal or Supraglottic Airway, Surfactant Administration through Thin Catheter
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 10 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Pooled it
  8. Guideline
  9. Sustained inflations and avoiding mechanical ventilation to prevent death or bronchopulmonary dysplasia: a meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2018
    Pooled it
  10. Pooled it
  11. Comparison of laryngeal mask airway and endotracheal tube placement in neonates.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Trial
  12. Predictors of successful treatment of respiratory distress with aerosolized calfactant.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Trial
  13. Nasal high-flow therapy to Optimise Stability during Intubation: the NOSI pilot trial.Archives of disease in childhood. Fetal and neonatal edition · 2023
    Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Review
  19. Prophylactic surfactant therapy in the era of less invasive surfactant delivery.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Kari D RobertsDepartment of Pediatrics, University of Minnesota, Minneapolis, MN. Electronic address: rober694@umn.edu.
Roland BrownDepartment of Biostatistics, University of Minnesota, Minneapolis, MN.
Andrea L LamplandDepartment of Pediatrics, University of Minnesota, Minneapolis, MN; Department of Pediatrics, Children's Minnesota, St. Paul, MN.
Tina A LeoneDepartment of Pediatrics, Columbia University, New York, NY.
Kyle D RudserDepartment of Biostatistics, University of Minnesota, Minneapolis, MN.
Neil N FinerDepartment of Pediatrics, University of California-San Diego, San Diego, CA.
Wade D RichDepartment of Pediatrics, Sharp Mary Birch, San Diego, CA.
T Allen MerrittDepartment of Pediatrics, Loma Linda University, Loma Linda, CA.
Adam J CzynskiDepartment of Pediatrics, Loma Linda University, Loma Linda, CA.
Julie M KesselDepartment of Pediatrics, University of Wisconsin-Madison, Madison, WI.
Sajani M TipnisDepartment of Pediatrics, University of Mississippi, Jackson, MS.
Erin C StepkaDepartment of Pediatrics, University of Minnesota, Minneapolis, MN.
Mark C MammelDepartment of Pediatrics, University of Minnesota, Minneapolis, MN; Department of Pediatrics, Children's Minnesota, St. Paul, MN.
University of Minnesota · USLoma Linda University · USColumbia University · USSharp Mary Birch Hospital for Women & Newborns · USUniversity of California San Diego · USUniversity of Mississippi · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine if preterm infants with moderate respiratory distress syndrome on continuous positive airway pressure (CPAP) who received surfactant via a laryngeal mask airway (LMA) would have a decreased rate of intubation and mechanical ventilation compared with those on CPAP who did not receive surfactant. STUDY

designIn this prospective, multicenter, randomized controlled trial, 103 premature infants 28

resultsSurfactant administration through an LMA (n = 50) significantly decreased the rate of intubation and mechanical ventilation compared with controls (n = 53): 38% vs 64%, respectively, OR 0.30 (95% CI 0.13, 0.70), P = .006, number needed to treat: 4). There were no serious adverse events associated with placement of the LMA or surfactant administration.

conclusionsIn premature neonates with moderate respiratory distress syndrome, surfactant administered through an LMA decreased the rate of intubation and mechanical ventilation. This intervention may have significant impact on clinical care in both high and low resource settings.

trial registrationClinicalTrials.gov: NCT01116921.

Indexed as

Laryngeal MasksContinuous Positive Airway PressureFemaleHumansInfant, NewbornInfant, PrematureIntubation, IntratrachealMaleProspective StudiesPulmonary SurfactantsRespiratory Distress Syndrome, NewbornTreatment FailureTreatment OutcomePulmonary Surfactantsinfantintubationpretermrespiratory distress syndrome

Identifiers

PMID29174079
OpenAlexW2769155935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.